Stock Markets January 22, 2026

Legato Merger Corp. IV Launches $200 Million IPO Targeting Tech and Infrastructure Sectors

Offering involves units with ordinary shares and redeemable warrants to trade separately on NYSE American

By Avery Klein
Legato Merger Corp. IV Launches $200 Million IPO Targeting Tech and Infrastructure Sectors

Legato Merger Corp. IV has priced its initial public offering at $10 per unit, securing $200 million through the sale of 20 million units. These public units, set to begin trading under the symbol "LEGO U" on the NYSE American, combine ordinary shares with partial redeemable warrants that separately trade as "LEGO" and "LEGO WS." The company aims to focus its acquisition strategy on sectors including infrastructure, industrial technology, and artificial intelligence.

Key Points

  • Legato Merger Corp. IV raised $200 million through an IPO pricing 20 million units at $10 each.
  • The company plans to target acquisitions in infrastructure, industrial, artificial intelligence, and technology sectors.
  • Units include one ordinary share and one-third of a redeemable warrant, with separate trading symbols for shares and warrants on NYSE American.
Legato Merger Corp. IV has announced the successful pricing of its initial public offering (IPO), raising a total of $200 million by issuing 20 million units at a price of $10 per unit. These financial instruments will start trading on the NYSE American exchange on January 23, 2026, under the ticker "LEGO U." Each unit comprises one ordinary share along with one-third of a redeemable warrant. When exercised fully, one complete redeemable warrant grants the investor the right to purchase one ordinary share at an exercise price of $11.50 per share. Following the commencement of trading, the ordinary shares and the warrants are expected to be listed separately, trading under the symbols "LEGO" and "LEGO WS," respectively. As a Cayman Islands-incorporated entity, Legato Merger Corp. IV is structured to seek out and complete mergers, acquisitions, or other business combinations. The company has identified its primary areas of interest to include infrastructure development, industrial operations, artificial intelligence, and technology-oriented businesses, signaling a strategic focus on sectors experiencing significant growth potential. In managing the IPO, BTIG, LLC functioned as the sole book-running manager, overseeing the financing effort. To facilitate potential overallotment and stabilize post-IPO share performance, the underwriting agreement includes a provision granting underwriters a 45-day option to acquire up to an additional 3 million units at the same offering price. This arrangement is typical in initial offerings to provide flexibility in meeting demand. The registration statement filed with the U.S. Securities and Exchange Commission (SEC) became effective on January 22, 2026, marking an official milestone in the company’s route to public trading. This entire financing endeavor is publicly disclosed through company press releases, outlining the company’s path forward in capital markets and its prospective acquisition strategy in high-impact sectors.

Risks

  • The company's future growth depends heavily on successful mergers or acquisitions in highly competitive technology and industrial markets.
  • Market conditions at the time of warrant exercise could influence investor willingness to purchase shares at $11.50, creating valuation risks.
  • The uncertainty inherent in identifying and integrating target businesses poses operational and financial risks for the company.

More from Stock Markets

Vanguard Lowers Fund Fees Again, Trimming Expense Ratios Across 53 Funds Feb 2, 2026 Snowflake Shares Edge Higher After $200 Million OpenAI Agreement Feb 2, 2026 Vanguard cuts fees on 53 index-backed funds and ETFs in second large reduction this year Feb 2, 2026 Insider Activity Spotlight: Major Purchases in Hycroft Mining Amid Heavy Volume; Multiple Executive Sales Across Tech and Energy Names Feb 2, 2026 60 Degrees Pharmaceuticals Shares Slide After GoodRx Deal to Offer Discounts on ARAKODA Feb 2, 2026